Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A

Tang,Yuanyuan; Cao,Ke; Wang,Qi; Chen,Jia; Liu,Rui; Wang,Shaohua; Zhou,Jianda; Xie,Huiqing

doi:10.3892/or.2016.4646

Silencing of CerS6 increases the invasion and glycolysis of melanoma WM35, WM451 and SK28 cell lines via increased GLUT1-induced downregulation of WNT5A

Authors:
- Yuanyuan Tang
- Ke Cao
- Qi Wang
- Jia Chen
- Rui Liu
- Shaohua Wang
- Jianda Zhou
- Huiqing Xie
View Affiliations

Affiliations: Department of Plastic Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China, Department of Oncology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China, Department of Rehabilitation, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China
Published online on: March 2, 2016 https://doi.org/10.3892/or.2016.4646
Pages: 2907-2915

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ceramide synthases (CerSs) have been shown to regulate numerous aspects of cancer development. CerS6 has been suggested to be involved in cancer etiology. However, little is known concerning the exact effect of CerS6 on the malignant behavior of melanoma, including glycolysis, proliferation and invasion. In the present study, we found that the expression of CerS6 was low in the melanoma cell lines, including WM35, WM451 and SK-28, and the expression level was related to the malignanct behavior of the melanoma cell lines. We constructed overexpression and silencing models of CerS6 in three melanoma cell lines and found that silencing of CerS6 promoted the ability of proliferation and invasion in the melanoma cell lines. Additionally, downregulation of CerS6 upregulated the activity of glycolysis-related enzyme, and enhanced the expression of glycolysis-related genes, including GLUT1 and MCT1. Furthermore, we identified the genes whose expression levels were changed after silencing of CerS6 by gene microarray. The expression of glycolysis-related gene SLC2A1 (also known as GLUT1) was found to be upregulated, while notably WNT5A was downregulated. The altered expression of GLUT1 and WNT5A was verified by qPCR and western blotting. Furthermore, silencing of GLUT1 in the melanoma cells resulted in the increased expression of WNT5A and the decreased ability of invasion and proliferation in the melanoma cells. Collectively, silencing of CerS6 induced the increased expression of GLUT1, which downregulated the expression of WNT5A and enhanced the invasion and proliferation of melanoma cells. Thus, CerS6 may provide a novel therapeutic target for melanoma treatment.

View Figures

View References

1	Xu D, Tan J, Zhou M, Jiang B, Xie H, Nie X, Xia K and Zhou J: Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncol Lett. 4:941–946. 2012.PubMed/NCBI
2	Thompson JF, Scolyer RA and Kefford RF: Cutaneous melanoma. Lancet. 365:687–701. 2005. View Article : Google Scholar : PubMed/NCBI
3	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
4	Stathem M, Marimuthu S, O'Neal J, Rathmell JC, Chesney JA, Beverly LJ and Siskind LJ: Glucose availability and glycolytic metabolism dictate glycosphingolipid levels. J Cell Biochem. 116:67–80. 2015. View Article : Google Scholar
5	Vander Heiden MG, Cantley LC and Thompson CB: Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
6	Warburg O: On the origin of cancer cells. Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
7	Hannun YA and Obeid LM: Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol. 9:139–150. 2008. View Article : Google Scholar : PubMed/NCBI
8	Ogretmen B: Sphingolipids in cancer: Regulation of pathogenesis and therapy. FEBS Lett. 580:5467–5476. 2006. View Article : Google Scholar : PubMed/NCBI
9	Ogretmen B and Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 4:604–616. 2004. View Article : Google Scholar : PubMed/NCBI
10	Mathias S, Peña LA and Kolesnick RN: Signal transduction of stress via ceramide. Biochem J. 335:465–480. 1998. View Article : Google Scholar : PubMed/NCBI
11	Knapp P, Baranowski M, Knapp M, Zabielski P, Błachnio-Zabielska AU and Górski J: Altered sphingolipid metabolism in human endometrial cancer. Prostaglandins Other Lipid Mediat. 92:62–66. 2010. View Article : Google Scholar : PubMed/NCBI
12	Wu J, Cheng Y, Nilsson A and Duan RD: Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis. 25:1327–1333. 2004. View Article : Google Scholar : PubMed/NCBI
13	Bektas M, Jolly PS, Müller C, Eberle J, Spiegel S and Geilen CC: Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: Role of Bcl-2 expression. Oncogene. 24:178–187. 2005. View Article : Google Scholar : PubMed/NCBI
14	Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A and Smyth MJ: The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate. 58:382–393. 2004. View Article : Google Scholar : PubMed/NCBI
15	Gouazé V, Liu YY, Prickett CS, Yu JY, Giuliano AE and Cabot MC: Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res. 65:3861–3867. 2005. View Article : Google Scholar : PubMed/NCBI
16	Levy M and Futerman AH: Mammalian ceramide synthases. IUBMB Life. 62:347–356. 2010.PubMed/NCBI
17	Pewzner-Jung Y, Ben-Dor S and Futerman AH: When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J Biol Chem. 281:25001–25005. 2006. View Article : Google Scholar : PubMed/NCBI
18	Teufel A, Maass T, Galle PR and Malik N: The longevity assurance homologue of yeast lag1 (Lass) gene family (Review). Int J Mol Med. 23:135–140. 2009.PubMed/NCBI
19	Harel R and Futerman AH: Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons. J Biol Chem. 268:14476–14481. 1993.PubMed/NCBI
20	Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z and Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell. 82:405–414. 1995. View Article : Google Scholar : PubMed/NCBI
21	Spassieva SD, Mullen TD, Townsend DM and Obeid LM: Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochem J. 424:273–283. 2009. View Article : Google Scholar : PubMed/NCBI
22	White-Gilbertson S, Mullen T, Senkal C, Lu P, Ogretmen B, Obeid L and Voelkel-Johnson C: Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene. 28:1132–1141. 2009. View Article : Google Scholar : PubMed/NCBI
23	Senkal CE, Ponnusamy S, Rossi MJ, Bialewski J, Sinha D, Jiang JC, Jazwinski SM, Hannun YA and Ogretmen B: Role of human longevity assurance gene 1 and C₁₈-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther. 6:712–722. 2007. View Article : Google Scholar : PubMed/NCBI
24	Senkal CE, Ponnusamy S, Bielawski J, Hannun YA and Ogretmen B: Antiapoptotic roles of ceramide-synthase-6-generated C₁₆-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J. 24:296–308. 2010. View Article : Google Scholar :
25	Zhou J, Liu R, Wang Y, Tang J, Tang S, Chen X, Xia K, Xiong W, Xu D, Wang S, et al: miR-199a-5p regulates the expression of metastasis-associated genes in B16F10 melanoma cells. Int J Clin Exp Pathol. 7:7182–7190. 2014.PubMed/NCBI
26	Zhou J, Xu D, Xie H, Tang J, Liu R, Li J, Wang S, Chen X, Su J, Zhou X, Xia K, He Q, Chen J, Xiong W, Cao P and Cao K: miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α. Cancer Biol Ther. 16:846–855. 2015. View Article : Google Scholar
27	Zhang Y, Liu H, Jin J, Zhu X, Lu L and Jiang H: The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Anticancer Drugs. 21:494–501. 2010. View Article : Google Scholar : PubMed/NCBI
28	Sun J, Han J, Zhu Q, Li Z and Hu J: Camptothecin fails to induce apoptosis in tumor necrosis factor-alpha-treated HaCaT cells. Pharmacology. 89:58–63. 2012. View Article : Google Scholar : PubMed/NCBI
29	Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, Jiang JC, Jazwinski SM, Hannun YA, et al: Defects in cell growth regulation by C_18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem. 279:44311–44319. 2004. View Article : Google Scholar : PubMed/NCBI
30	Karahatay S, Thomas K, Koybasi S, Senkal CE, Elojeimy S, Liu X, Bielawski J, Day TA, Gillespie MB, Sinha D, et al: Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): Attenuation of C₁₈-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 256:101–111. 2007. View Article : Google Scholar : PubMed/NCBI
31	Weinmann A, Galle PR and Teufel A: LASS6, an additional member of the longevity assurance gene family. Int J Mol Med. 16:905–910. 2005.PubMed/NCBI
32	Novgorodov SA, Chudakova DA, Wheeler BW, Bielawski J, Kindy MS, Obeid LM and Gudz TI: Developmentally regulated ceramide synthase 6 increases mitochondrial Ca²⁺ loading capacity and promotes apoptosis. J Biol Chem. 286:4644–4658. 2011. View Article : Google Scholar :
33	Sherwood V, Chaurasiya SK, Ekström EJ, Guilmain W, Liu Q, Koeck T, Brown K, Hansson K, Agnarsdóttir M, Bergqvist M, et al: WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis. 35:784–794. 2014. View Article : Google Scholar :
34	Grossmann AH, Yoo JH, Clancy J, Sorensen LK, Sedgwick A, Tong Z, Ostanin K, Rogers A, Grossmann KF, Tripp SR, et al: The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal. 6:ra142013. View Article : Google Scholar
35	Mullen TD, Spassieva S, Jenkins RW, Kitatani K, Bielawski J, Hannun YA and Obeid LM: Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism. J Lipid Res. 52:68–77. 2011. View Article : Google Scholar :